Search results for "cell-pattern-formation-associated-protein"

Toll-like receptor 4, Monoclonal Antibody (Cat# AAA834441)

Full Name

Toll-like receptor 4 antibody

Gene Names

TLR4; TOLL; CD284; TLR-4; ARMD10

Applications

User optimized

Purity

Toll-like receptor 4 antibody was purified by affinity chromatography.

Pricing

$365/0.05 mg | $1,625/5x0.05 mg

Toll-like receptor 4, Monoclonal Antibody (Cat# AAA834178)

Full Name

Toll-like receptor 4 antibody (allophycocyanin)

Applications

FC/FACS

Pricing

$980/0.1 mg | $4,410/5x0.1 mg

Cell pattern formation-associated protein stuA (stuA), partial, Recombinant Protein (Cat# AAA1056708)

Full Name

Recombinant Emericella nidulans Cell pattern formation-associated protein stuA (stuA), partial

Purity

Greater or equal to 85% purity as determined by SDS-PAGE.

< >

<< Previous Next >>

Western Blot (WB) (Western blot analysis of Amyloid-Î²A4 (Phospho-Thr729) using Hela whole cell lysates.-/+ means absence or presence of N peptideï¼ˆnon-phospho peptide) and P peptide(phospho peptide).)

APP, Polyclonal Antibody (Cat# AAA9614454)

Full Name

Phospho-APP (Thr729) Antibody

Gene Names

APP; AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; CTFgamma

Reactivity

Human, Mouse, Rat
Predicted Reactivity: Pig (100%), Horse (100%), Chicken (100%), Xenopus (86%)

Applications

WB, IHC, IF, ICC, EIA

Purity

The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.

Pricing

$245/0.05 mL | $310/0.1 mL | $370/0.2 mL | $1,605/5x0.2 mL

Lmtk3, Blocking Peptide (Cat# AAA9230292)

Full Name

Mouse Lmtk3 Blocking Peptide (Center)

Gene Names

Lmtk3; aatyk3; BC059845

< >

<< Previous Next >>

Testing Data (Surface Staining of buffy coat differentiated monocytes by Mouse anti Human CD169:RPE )

Testing Data (PE conjugated Mouse anti CD169 antibody, clone 7-239 used for the evaluation of CD169 expression on myeloid cell populations by flow cytometry. Mouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeliod cells.Image caption:Siglec-1 mediates HIV-1 capture by IFN?-treated myeloid cells. A. Representative profiles of Siglec-1 staining in distinct myeloid cells cultured with or without 1000 U/ml of IFN? and assessed by FACS. Staining of matched-isotype control is also shown. The mean fold increase in fluorescence after IFN&apha; treatment of cells derived from three donors is shown in red numbers. B. Mean number of Siglec-1 antibody binding sites per cell displayed by different myeloid cells exposed to 1000 U/ml of IFN? for 48 h and assessed by quantitative FACS analysis. Data show mean values and SEM from four experiments including cells from 12 donors. C. Comparative binding of HIV-1NL4–3 to different myeloid cells ly exposed to 1000 U/ml of IFN? for 48 h. Cells were cultured with HIV-1NL4–3 for 4 h at 4°C, washed and lysed to measure p24Gag by ELISA. Data show mean values and SEM from two experiments including cells from six donors. D. Relative binding of HIV-1NL4–3 by different IFN?-treated myeloid cells that had been pre-incubated with 10 ug/ml of the indicated mAbs before HIV-1 exposure for 4 h at 4°C as described in C. To compare the effect of the mAbs in different myeloid cells, values were normalized to the level of HIV-1 binding by mock-treated cells (set to 100%). Data show mean values and SEM from two experiments including cells from six donors. Statistical differences were assessed with a paired t test in B and C, and with a one sample t-test in D.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

Testing Data (PE conjugatedMouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeloid cells.Image caption:Siglec-1 mediates HIV-1 uptake into a storage compartment and enhances HIV-1 trans-infection specially in IFN?-treated monocytes and DCs. A. Uptake of HIV-1NL4–3 by different myeloid cells exposed to IFN?. Cells were cultured with HIV-1 to measure p24Gag by ELISA. Mean values and SEM from four experiments include cells from 12 donors. B. Fold change in HIV-1NL4–3 uptake of cells treated with bafilomycin A1 compared to untreated cells. Mean values and SEM include cells from three donors. C. Relative uptake of HIV-1NL4–3 by IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 uptake by mock-treated cells (set at 100%). Mean values and SEM from two experiments include cells from six donors. D. Confocal microscopy analysis of different IFN?-treated myeloid cells pulsed with HIV-1Cherry and stained for Siglec-1 (Alexa 488), HLA-DR (Alexa 647) and DAPI. (Top) Representative viral pattern for each kind of myeloid cell analyzed, showing maximum fluorescence intensity of four channels. (Bottom) Percentage of myeloid cells with distinct viral patterns: random distribution, polarized accumulation, and sac-like compartment formation, as illustrated in the left drawing. Mean values of 50 cells from two different donors are shown. E. HIV-1 transmission from IFN?-treated myeloid cells to a luciferase reporter CD4+ cell line. HIV-1 infection was determined by induced luciferase activity in relative light units (RLUs). Mean values and SEM from four experiments include cells from 12 donors. F. Relative HIV-1 transmission from IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 trans-infected by mock-treated cells. Mean values and SEM from two experiments include cells from six donors. Statistical differences were assessed with a paired t test in A and E, and with a one sample t-test in B, C and F.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

CD169, Monoclonal Antibody (Cat# AAA225766)

Full Name

Mouse Anti Human CD169: APC

Gene Names

SIGLEC1; SN; CD169; SIGLEC-1

Reactivity

Human

Applications

FC/FACS

Purity

>95% by SDS PAGE
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Pricing

$555/100 Tests | $2,340/5x100 Tests

LGR4 / Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 4, Recombinant Protein (Cat# AAA2902235)

Full Name

Human LGR4 / Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 4 Recombinant Protein

Gene Names

LGR4; GPR48; BNMD17

Applications

EIA, WB, AP

Purity

>95% by SDS-PAGE

< >

<< Previous Next >>

Testing Data (Surface Staining of buffy coat differentiated monocytes by Mouse anti Human CD169:RPE )

Testing Data (PE conjugated Mouse anti CD169 antibody, clone 7-239 used for the evaluation of CD169 expression on myeloid cell populations by flow cytometry. Mouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeliod cells.Image caption:Siglec-1 mediates HIV-1 capture by IFN?-treated myeloid cells. A. Representative profiles of Siglec-1 staining in distinct myeloid cells cultured with or without 1000 U/ml of IFN? and assessed by FACS. Staining of matched-isotype control is also shown. The mean fold increase in fluorescence after IFN&apha; treatment of cells derived from three donors is shown in red numbers. B. Mean number of Siglec-1 antibody binding sites per cell displayed by different myeloid cells exposed to 1000 U/ml of IFN? for 48 h and assessed by quantitative FACS analysis. Data show mean values and SEM from four experiments including cells from 12 donors. C. Comparative binding of HIV-1NL4–3 to different myeloid cells ly exposed to 1000 U/ml of IFN? for 48 h. Cells were cultured with HIV-1NL4–3 for 4 h at 4°C, washed and lysed to measure p24Gag by ELISA. Data show mean values and SEM from two experiments including cells from six donors. D. Relative binding of HIV-1NL4–3 by different IFN?-treated myeloid cells that had been pre-incubated with 10 ug/ml of the indicated mAbs before HIV-1 exposure for 4 h at 4°C as described in C. To compare the effect of the mAbs in different myeloid cells, values were normalized to the level of HIV-1 binding by mock-treated cells (set to 100%). Data show mean values and SEM from two experiments including cells from six donors. Statistical differences were assessed with a paired t test in B and C, and with a one sample t-test in D.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

Testing Data (PE conjugatedMouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeloid cells.Image caption:Siglec-1 mediates HIV-1 uptake into a storage compartment and enhances HIV-1 trans-infection specially in IFN?-treated monocytes and DCs. A. Uptake of HIV-1NL4–3 by different myeloid cells exposed to IFN?. Cells were cultured with HIV-1 to measure p24Gag by ELISA. Mean values and SEM from four experiments include cells from 12 donors. B. Fold change in HIV-1NL4–3 uptake of cells treated with bafilomycin A1 compared to untreated cells. Mean values and SEM include cells from three donors. C. Relative uptake of HIV-1NL4–3 by IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 uptake by mock-treated cells (set at 100%). Mean values and SEM from two experiments include cells from six donors. D. Confocal microscopy analysis of different IFN?-treated myeloid cells pulsed with HIV-1Cherry and stained for Siglec-1 (Alexa 488), HLA-DR (Alexa 647) and DAPI. (Top) Representative viral pattern for each kind of myeloid cell analyzed, showing maximum fluorescence intensity of four channels. (Bottom) Percentage of myeloid cells with distinct viral patterns: random distribution, polarized accumulation, and sac-like compartment formation, as illustrated in the left drawing. Mean values of 50 cells from two different donors are shown. E. HIV-1 transmission from IFN?-treated myeloid cells to a luciferase reporter CD4+ cell line. HIV-1 infection was determined by induced luciferase activity in relative light units (RLUs). Mean values and SEM from four experiments include cells from 12 donors. F. Relative HIV-1 transmission from IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 trans-infected by mock-treated cells. Mean values and SEM from two experiments include cells from six donors. Statistical differences were assessed with a paired t test in A and E, and with a one sample t-test in B, C and F.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

CD169, Monoclonal Antibody (Cat# AAA225768)

Full Name

Mouse Anti Human CD169: RPE

Gene Names

SIGLEC1; SN; CD169; SIGLEC-1

Reactivity

Human

Applications

FC/FACS

Purity

>95% by SDS PAGE
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Pricing

$555/100 Tests | $2,340/5x100 Tests

CEACAM1 / Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1, Recombinant Protein (Cat# AAA2902477)

Full Name

Human CEACAM1 / Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Recombinant Protein

Gene Names

CEACAM1; BGP; BGP1; BGPI

Applications

EIA, WB, AP

Purity

>95% by SDS-PAGE

beta Amyloid 1-42, Polyclonal Antibody (Cat# AAA9629019)

Full Name

beta Amyloid 1-42 Antibody

Gene Names

APP; AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; CTFgamma

Reactivity

Human

Applications

EIA, peptide

Purity

The antiserum was purified by peptide affinity chromatography using SulfoLink Coupling Resin (Thermo Fisher Scientific).

Pricing

$260/0.1 mL | $305/0.2 mL | $1,220/5x0.2 mL

< >

<< Previous Next >>

Testing Data (Surface Staining of buffy coat differentiated monocytes by Mouse anti Human CD169:RPE )

Testing Data (PE conjugated Mouse anti CD169 antibody, clone 7-239 used for the evaluation of CD169 expression on myeloid cell populations by flow cytometry. Mouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeliod cells.Image caption:Siglec-1 mediates HIV-1 capture by IFN?-treated myeloid cells. A. Representative profiles of Siglec-1 staining in distinct myeloid cells cultured with or without 1000 U/ml of IFN? and assessed by FACS. Staining of matched-isotype control is also shown. The mean fold increase in fluorescence after IFN&apha; treatment of cells derived from three donors is shown in red numbers. B. Mean number of Siglec-1 antibody binding sites per cell displayed by different myeloid cells exposed to 1000 U/ml of IFN? for 48 h and assessed by quantitative FACS analysis. Data show mean values and SEM from four experiments including cells from 12 donors. C. Comparative binding of HIV-1NL4–3 to different myeloid cells ly exposed to 1000 U/ml of IFN? for 48 h. Cells were cultured with HIV-1NL4–3 for 4 h at 4°C, washed and lysed to measure p24Gag by ELISA. Data show mean values and SEM from two experiments including cells from six donors. D. Relative binding of HIV-1NL4–3 by different IFN?-treated myeloid cells that had been pre-incubated with 10 ug/ml of the indicated mAbs before HIV-1 exposure for 4 h at 4°C as described in C. To compare the effect of the mAbs in different myeloid cells, values were normalized to the level of HIV-1 binding by mock-treated cells (set to 100%). Data show mean values and SEM from two experiments including cells from six donors. Statistical differences were assessed with a paired t test in B and C, and with a one sample t-test in D.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

Testing Data (PE conjugatedMouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeloid cells.Image caption:Siglec-1 mediates HIV-1 uptake into a storage compartment and enhances HIV-1 trans-infection specially in IFN?-treated monocytes and DCs. A. Uptake of HIV-1NL4–3 by different myeloid cells exposed to IFN?. Cells were cultured with HIV-1 to measure p24Gag by ELISA. Mean values and SEM from four experiments include cells from 12 donors. B. Fold change in HIV-1NL4–3 uptake of cells treated with bafilomycin A1 compared to untreated cells. Mean values and SEM include cells from three donors. C. Relative uptake of HIV-1NL4–3 by IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 uptake by mock-treated cells (set at 100%). Mean values and SEM from two experiments include cells from six donors. D. Confocal microscopy analysis of different IFN?-treated myeloid cells pulsed with HIV-1Cherry and stained for Siglec-1 (Alexa 488), HLA-DR (Alexa 647) and DAPI. (Top) Representative viral pattern for each kind of myeloid cell analyzed, showing maximum fluorescence intensity of four channels. (Bottom) Percentage of myeloid cells with distinct viral patterns: random distribution, polarized accumulation, and sac-like compartment formation, as illustrated in the left drawing. Mean values of 50 cells from two different donors are shown. E. HIV-1 transmission from IFN?-treated myeloid cells to a luciferase reporter CD4+ cell line. HIV-1 infection was determined by induced luciferase activity in relative light units (RLUs). Mean values and SEM from four experiments include cells from 12 donors. F. Relative HIV-1 transmission from IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 trans-infected by mock-treated cells. Mean values and SEM from two experiments include cells from six donors. Statistical differences were assessed with a paired t test in A and E, and with a one sample t-test in B, C and F.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

CD169, Monoclonal Antibody (Cat# AAA225767)

Full Name

Mouse Anti Human CD169

Gene Names

SIGLEC1; SN; CD169; SIGLEC-1

Reactivity

Human

Applications

IHC, FC/FACS, FN, IP, WB

Purity

>95% by SDS PAGE
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Pricing

$380/0.1 mg | $1,565/5x0.1 mg

RNF8, Polyclonal Antibody (Cat# AAA9629157)

Full Name

RNF8 Antibody

Gene Names

RNF8; hRNF8

Reactivity

Human, Mouse, Rat

Applications

EIA, peptide

Purity

The antiserum was purified by peptide affinity chromatography using SulfoLink Coupling Resin (Thermo Fisher Scientific).

Pricing

$260/0.1 mL | $305/0.2 mL | $1,220/5x0.2 mL

PODXL, Polyclonal Antibody (Cat# AAA9630757)

Full Name

PODXL Antibody

Gene Names

PODXL; PC; PCLP; Gp200; PCLP-1

Reactivity

Human, Mouse, Rat

Applications

EIA, peptide

Purity

The antiserum was purified by peptide affinity chromatography using SulfoLink Coupling Resin (Thermo Fisher Scientific).

Pricing

$260/0.1 mL | $305/0.2 mL | $1,220/5x0.2 mL

Loading...

Filters

Clonality

Type

Reactivity

Gene Name

Isotype

Host

Application

Clone

13 results for "cell-pattern-formation-associated-protein" - showing 1-13

Toll-like receptor 4, Monoclonal Antibody (Cat# AAA834441)

Toll-like receptor 4, Monoclonal Antibody (Cat# AAA834178)

Cell pattern formation-associated protein stuA (stuA), partial, Recombinant Protein (Cat# AAA1056708)

APP, Polyclonal Antibody (Cat# AAA9614454)

Lmtk3, Blocking Peptide (Cat# AAA9230292)

CD169, Monoclonal Antibody (Cat# AAA225766)

LGR4 / Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 4, Recombinant Protein (Cat# AAA2902235)

CD169, Monoclonal Antibody (Cat# AAA225768)

CEACAM1 / Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1, Recombinant Protein (Cat# AAA2902477)

beta Amyloid 1-42, Polyclonal Antibody (Cat# AAA9629019)

CD169, Monoclonal Antibody (Cat# AAA225767)

RNF8, Polyclonal Antibody (Cat# AAA9629157)

PODXL, Polyclonal Antibody (Cat# AAA9630757)

Contact us by

Loading...

Filters

Clonality

Type

Reactivity

Gene Name

Isotype

Host

Application

Clone

13 results for "cell-pattern-formation-associated-protein" - showing 1-13

Toll-like receptor 4, Monoclonal Antibody (Cat# AAA834441)

Toll-like receptor 4, Monoclonal Antibody (Cat# AAA834178)

Cell pattern formation-associated protein stuA (stuA), partial, Recombinant Protein (Cat# AAA1056708)

APP, Polyclonal Antibody (Cat# AAA9614454)

Lmtk3, Blocking Peptide (Cat# AAA9230292)

CD169, Monoclonal Antibody (Cat# AAA225766)

LGR4 / Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 4, Recombinant Protein (Cat# AAA2902235)

CD169, Monoclonal Antibody (Cat# AAA225768)

CEACAM1 / Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1, Recombinant Protein (Cat# AAA2902477)

beta Amyloid 1-42, Polyclonal Antibody (Cat# AAA9629019)

CD169, Monoclonal Antibody (Cat# AAA225767)

RNF8, Polyclonal Antibody (Cat# AAA9629157)

PODXL, Polyclonal Antibody (Cat# AAA9630757)

Contact us by

Request more Information

Request a Manual

Request a Quote